Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Gross

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
The COPD Pipeline XXXIIINicholas Gross
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
The COPD Pipeline XXXVNicholas Gross
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|January 23, 2018
The COPD Pipeline XXXVINicholas Gross
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|October 31, 2018
The COPD Pipeline XXXVIIINicholas Gross
COPD|May 2, 2012
The COPD pipeline XVINicholas Gross, Marianne Mann
The American Journal of Medicine|July 2, 2008
Primary care of the patient with chronic obstructive pulmonary disease-part 2: pharmacologic treatment across all stages of diseaseNicholas Gross, David Levin
The European Respiratory Journal|August 18, 2018
The mode of action of anticholinergics in asthmaReinoud Gosens, Nicholas Gross
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 31, 2022
A multinational, drug utilization study of lipegfilgrastim use in real-world setting in EuropeSigal Kaplan, Dana Ilic Bogojevic, Carolyn Rainville, et al.
Annals of the American Thoracic Society|January 28, 2014
Self-management in chronic obstructive pulmonary disease. Time for a paradigm shift?Linda Nici, Thomas D Bontly, Richard Zuwallack, et al.
Journal of Affective Disorders|March 13, 2016
Long-term safety and efficacy of armodafinil in bipolar depression: A 6-month open-label extension studyTerence A Ketter, Jess Amchin, Mark A Frye, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
The COPD Pipeline XXXIIINicholas Gross
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
The COPD Pipeline XXXVNicholas Gross
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|January 23, 2018
The COPD Pipeline XXXVINicholas Gross
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|October 31, 2018
The COPD Pipeline XXXVIIINicholas Gross
COPD|May 2, 2012
The COPD pipeline XVINicholas Gross, Marianne Mann
The American Journal of Medicine|July 2, 2008
Primary care of the patient with chronic obstructive pulmonary disease-part 2: pharmacologic treatment across all stages of diseaseNicholas Gross, David Levin
The European Respiratory Journal|August 18, 2018
The mode of action of anticholinergics in asthmaReinoud Gosens, Nicholas Gross
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 31, 2022
A multinational, drug utilization study of lipegfilgrastim use in real-world setting in EuropeSigal Kaplan, Dana Ilic Bogojevic, Carolyn Rainville, et al.
Annals of the American Thoracic Society|January 28, 2014
Self-management in chronic obstructive pulmonary disease. Time for a paradigm shift?Linda Nici, Thomas D Bontly, Richard Zuwallack, et al.
Journal of Affective Disorders|March 13, 2016
Long-term safety and efficacy of armodafinil in bipolar depression: A 6-month open-label extension studyTerence A Ketter, Jess Amchin, Mark A Frye, et al.
Pageof 4